Clinical Trials
13. June 2022
Clinical Trials
13. June 2022
The course
Recruitment to the REMED study on COVID-19 in serious condition was terminated on March 9, 2022 due to a receding pandemic. The sponsor of this clinical trial is the University Hospital Brno and is implemented in cooperation with the CZECRIN research infrastructure. 8 centers across the Czech Republic are actively involved in the study, which included a total of 235 patients out of 300 planned. A statistical evaluation of the primary objective and the preparation of a publication are currently underway. Enrolled patients will be followed up in the study according to the approved protocol.
CZECRIN Office
Faculty of Medicine, Masaryk University Department of Pharmacology LRI CZECRIN Kamenice 5,625 00 Brno, Česká Republika
Info@czecrin.cz Phone: +420 549 498 165 Phone: +420 725 828 348